Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Robert Peveler a Mental Health Group, University
of Southampton, Royal South Hants Hospital, Southampton SO14 0YG, b Clinical Pharmacology Group, Biomedical Sciences Building,
Southampton SO16 7PX, c General Practice and
Primary Care Unit, Institute of Public Health Medicine, University of
Cambridge, Cambridge CB2 2SR, d School of Health and
Related Research, University of Sheffield, Northern General Hospital,
Sheffield S5 7AU
Correspondence to: R Peveler rcp{at}soton.ac.uk
Objectives:
To evaluate two different methods of
improving adherence to antidepressant drugs.
Design:
Factorial randomised controlled single blind trial of treatment leaflet, drug counselling, both, or treatment as usual.
Setting:
Primary care in Wessex
Participants:
250 patients starting treatment with
tricyclic antidepressants.
Main outcome measures:
Adherence to drug treatment (by
confidential self report and electronic monitor); depressive symptoms
and health status.
Results:
66 (63%) patients continued with drugs to 12 weeks in the counselled group compared with 42 (39%) of
those who did not receiving counselling (odds ratio 2.7, 95%
confidence interval 1.6 to 4.8; number needed to
treat=4). Treatment leaflets had no significant
effect on adherence. No differences in depressive symptoms were found
between treatment groups overall, although a significant improvement
was found in patients with major depressive disorder receiving drug
doses of at least 75 mg (depression score 4 (SD 3.7) counselling
v 5.9 (SD 5.0) no counselling, P=0.038).
Conclusions:
Counselling about drug treatment
significantly improved adherence, but clinical benefit was seen only in
patients with major depressive disorder receiving doses
75 mg.
Further research is required to evaluate the effect of this approach in combination with appropriate targeting of treatment and advice about dosage.
Key messages
Read all Rapid Responses